Low Vitamin C in Psych Unit; MDMA Tested in Schizophrenia; Prison for Opioid Doc

Among patients in a psychiatric unit setting, 64% met criteria for mild vitamin C deficiency. (Journal of Clinical Psychiatry)

Many suicide hotlines promise anonymity while sending sensitive data about visitors to Facebook. (The Markup)

Fewer than one in four residential addiction treatment facilities for adolescents offered buprenorphine for opioid use disorder, according to a “secret shopper” study. (JAMA)

Nearly 15% of youths ages 5 to 17 received mental health treatment in the past 12 months, according to data from the 2021 National Health Interview Survey. (National Center for Health Statistics)

Yale researchers were awarded a $1 million federal grant to test MDMA and methylone as possible treatments for veterans with post-traumatic stress disorder.

The FDA gave the green light to a clinical trial testing MDMA capsules in schizophrenia, said PharmAla Biotech.

A California doctor was sentenced to over 12 years in prison for illegally distributing opioids to patients with known addictions. (Becker’s ASC Review)

Lesbian, gay, and bisexual adults were more likely than straight adults to use substances, experience mental health issues including major depressive episodes, and have serious thoughts of suicide, according to new survey data from the Substance Abuse and Mental Health Services Administration.

Researchers pinpointed 35 drug-gene pairs with shared risk pathways across both bipolar disorder and schizophrenia, opening the door for possible drug repurposing. (JAMA Psychiatry)